Lipoprotein(a) and residual cardiovascular risks in Japanese patients with coronary artery disease who achieve guideline-recommended low-density lipoprotein cholesterol goals

European Heart Journal 2026 Open access

Read full text
Authors: Y K Kataoka, Kausik K Ray, Stephen J Nicholls, Aya Katasako-Yabumoto, Satoshi Kitahara, Hayato Hosoda, Kentarou Mitsui, Kota Murai, K S Sawada, Hideo Matama, Takamasa Iwai, S H Honda
+6 more Masashi Fujino, Shuichi Yoneda, K N Nakao, K T Takagi, Y A Asaumi, Teruo Noguchi
DOI: 10.1093/eurheartj/ehag446
Cited by: 5
References: 45

Abstract

BACKGROUND AND AIMS: Current guidance recommends better low-density lipoprotein cholesterol (LDL-C) control in patients with elevated lipoprotein(a) [Lp(a)] as Lp(a) lowering therapies are unavailable. Whether risks attributable to Lp(a) are mitigated in patients with coronary artery disease (CAD) who achieve LDL-C

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health HIV-related health complications and treatments Acute Myocardial Infarction Research

Publication details

Journal / source
European Heart Journal
Publisher
Oxford University Press (OUP)
Publication date
19 May 2026
Language
EN